Tajenta-M 2.5 mg+500 mg (Tablet)
Unit Price: ৳ 12.00 (2 x 10: ৳ 240.00)
Strip Price: ৳ 120.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Linagliptin metformin hydrochloride |
| Company | Goodman pharmaceuticals ltd |
| Also available as |
Title and Category
- Tajenta-M Tablet
- Combination Oral hypoglycemic preparations
Dimensions
- Standard tablet size
Color Options
- No specific color options
Functions
- Improves glycemic control in adults with type 2 diabetes mellitus
- Adjunct to diet and exercise
- Inhibits DPP-4 enzyme
- Stimulates insulin release in a glucose-dependent manner
- Decreases glucagon secretion
- Lowers both basal and postprandial plasma glucose
- Decreases hepatic glucose production
- Improves insulin sensitivity
- Indicated as an immediate release or extended release tablet
Materials
- Contains Linagliptin and Metformin Hydrochloride
Technical Specifications
- Maximum recommended dose of 2.5 mg Linagliptin and 1000 mg Metformin Hydrochloride (immediate release)
- Maximum recommended total daily dose of Linagliptin 5 mg and Metformin Hydrochloride 2000 mg (extended release)
Design Elements
- Film-coated tablets
- Immediate release or extended release format
Usability Features
- Individualized dosage based on effectiveness and tolerability
- Gradual dose escalation
- Once daily administration (extended release)
Interaction
- Potential interaction with cationic drugs
- Interaction with carbonic anhydrase inhibitors
- Interaction with inducers of P-glycoprotein and CYP3A4 enzymes
- Effect on drugs affecting glycemic control
Contraindications
- Contraindicated in patients with renal impairment
- Contraindicated in acute or chronic metabolic acidosis
- Contraindicated in hypersensitivity to Linagliptin or Metformin Hydrochloride
Side Effects
- Common side effects include nasopharyngitis and diarrhea
- Increased risk of hypoglycemia in patients treated with Tajenta-M and sulfonylureas
Pregnancy & Lactation
- No adequate and well-controlled studies in pregnant women
- Caution advised during pregnancy and lactation
Precautions & Warnings
- Discontinue in case of lactic acidosis or suspected pancreatitis
- Temporary discontinuation for radiologic studies or surgical procedures
- Monitoring of Vitamin B12 levels
- Potential for lactic acidosis under certain conditions
Overdose Effects
- Usual supportive measures in case of overdose
- Dialyzable in case of Metformin Hydrochloride overdose
Storage Conditions
- Store in a cool & dry place (below 30°C)
- Protect from light & moisture
- Keep out of reach of children
Related Brands
- Lino-M 2.5 mg+1000 mg (Tablet) - acme-laboratories-ltd
- Linax Plus 5 mg+1000 mg (Tablet (Extended Release)) - ibn-sina-pharmaceuticals-ltd
- Metfolin 2.5 mg+500 mg (Tablet) - doctor-tims-pharmaceuticals-ltd
- Liglimet XR 5 mg+1000 mg (Tablet (Extended Release)) - square-pharmaceuticals-plc
- Linera M 2.5 mg+1000 mg (Tablet) - ziska-pharmaceuticals-ltd